FDA approves cabozantinib to treat rare type of thyroid cancer

A recent study found that there was a significant relationship between self-efficacy for disease control and the level of glycemic control.

Tom Utech, PharmD, CEO of iA, joined Drug Topics to discuss his company’s centralized pharmacy fulfillment solutions.

Individuals who received tailored text message reminders about receiving a COVID-19 booster vaccine were more likely to get it.

Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.

Benjamin Jolley, PharmD, pharmacist at Jolley’s Compounding Pharmacy in Salt Lake City, Utah, discussed the state of independent pharmacy.

FDA approval was granted on September 13, 2024.